PPARY2

/ SCIENCE / By
  1. 2-Methylene-19-Nor-1Ī‘-Hydroxyvitamin D3 Analogs Inhibit Adipocyte Differentiation And PparĪ³2 Gene Transcription
  2. A 45 Kda Protein Related To PparĪ³2, Induced By Peroxisome Proliferators, Is Located In The Mitochondrial Matrix
  3. A Effect Of PparĪ³2 Genetic Polymorphism On Dietary Intervention In Hyperglycemia People.
  4. A Novel 3T3-L1 Preadipocyte Variant That Expresses PparĪ³2 And RxrĪ± But Does Not Undergo Differentiation
  5. A Novel Screening Method Identifies Usp7 As A PparĪ³2 Regulator
  6. A Novel Splicing Variant Of Peroxisome Proliferator-Activated Receptor-Ī“ (PparĪ³1Sv) Cooperatively Regulates Adipocyte Differentiation With PparĪ³2
  7. A Population-Based Study Of PparĪ³2 Gene Polymorphism For Type 2 Diabetes
  8. A Pro 12 Ala Substitution In The PparĪ³2 Polymorphism May Decrease The Number Of Diseased Vessels And The Severity Of Angiographic Coronary Artery
  9. A Pro12Ala Substitution In PparĪ³2 Associated With Decreased Receptor Activity, Lower Body Mass Index And Improved Insulin Sensitivity
  10. Aberrant Hepatic Expression Of PparĪ³2 Stimulates Hepatic Lipogenesis In A Mouse Model Of Obesity, Insulin Resistance, Dyslipidemia, And Hepatic Steatosis
  11. Activation Of PparĪ³2 By PparĪ³1 Through A Functional Ppre In Transdifferentiation Of Myoblasts To Adipocytes Induced By Epa
  12. Adiponectin Gene Activation By Thiazolidinediones Requires PparĪ³2, But Not C/EbpĪ±ā€”Evidence For Differential Regulation Of The Ap2 And Adiponectin Genes
  13. Adiponectin Inhibits Lps-Induced Nf-Īšb Activation And Il-6 Production And Increases PparĪ³2 Expression In Adipocytes
  14. Adrb3 And PparĪ³2 Gene Polymorphisms And Their Association With Cardiovascular Disease Risk In Postmenopausal Women
  15. Alcohol Intake Modulates The Genetic Association Between Hdl Cholesterol And The PparĪ³2 Pro12Ala Polymorphism
  16. An Evi1-C/EbpĪ² Complex Controls PparĪ³2 Expression To Initiate White Fat Cell Differentiation
  17. An Increase In Liver PparĪ³2 Is An Initial Event To Induce Fatty Liver In Response To A Diet High In Butter: PparĪ³2 Knockdown Improves Fatty Liver Induced By High ā€¦
  18. Analysis Of Pgc-1Ī‘ Variants Gly482Ser And Thr612Met Concerning Their PparĪ³2-Coactivation Function
  19. Antiadipogenesis Of Oroxylum Indicum (L.) Kurz Extract Via PparĪ³2 In 3T3-L1 Adipocytes
  20. Aronia Melanocarpa Extract Ameliorates Hepatic Lipid Metabolism Through PparĪ³2 Downregulation
  21. Association Between Pro12Ala Polymorphism At The PparĪ³2 Gene And Insulin Sensitivity In South Indian Population With Type 2 Diabetes Mellitus
  22. Association Of Mthfr And PparĪ³2 Gene Polymorphisms In Relation To Type 2 Diabetes Mellitus Cases Among North Indian Population
  23. Association Of PparĪ³2 (Pro12Ala) And Neuropeptide Y (Leu7Pro) Gene Polymorphisms With Obstructive Sleep Apnea In Obese Asian Indians
  24. Association Of PparĪ³2 Gene C1431T Polymorphism To Serum Adipokines In Women With Poly Cystic Ovary Syndrome
  25. Association Of PparĪ³2 Gene Pro12Ala Polymorphism With Abdominal Obesity Index Whr In Liaoning Population
  26. Association Of PparĪ³2 Gene Pro12Ala Polymorphism With Over Weight And Obesity Of Older Persons
  27. Association Of PparĪ³2 Gene Pro12Ala Polymorphism With Overweight And Obesity.
  28. Association Of PparĪ³2 Gene Variant Pro12Ala Polymorphism With Hypertension And Obesity In The Aboriginal Qatari Population Known For Being ā€¦
  29. Association Of PparĪ³2 Polymorphisms With Carcass And Meat Quality Traits In A Pietrain X Jinhua F2 Population
  30. Association Of Pro12Ala And C1431T Polymorphisms Of PparĪ³2 Gene With Metabolic Syndrome In Xinjiang Kazakh [J]
  31. Association Of Pro12Ala Polymorphism Of Peroxisome Proliferator-Activated Receptor Gamma 2 (PparĪ³2) Gene With Type 2 Diabetes Mellitus In Ethnic Kashmiri ā€¦
  32. Association Of The Human PparĪ³2 Pro12Ala Polymorphism With Obesity In A Population From Turkey
  33. Association Of The PparĪ³2 Pro12Ala Polymorphism With Increased Risk Of Cardiovascular Diseases
  34. Association Of The Pro12Ala Polymorphism In PparĪ³2 Gene With Blood Glucose Levels In Patients With Primary Hypertension Of Chengdu
  35. Association Of Variants In PparĪ³2, Igf2Bp2, And Kcnq1 With A Susceptibility To Gestational Diabetes Mellitus In A Korean Population
  36. Autophagy Is Involved In Adipogenic Differentiation By Repressesing Proteasome-Dependent PparĪ³2 Degradation
  37. Befs-PparĪ³2 Cells Incubated With Trans-11 C18:1 Exhibit More Beneficial Fatty Acid Synthesis
  38. Bone Marrow Adipogenesis In Senescence Accelerated Mice (Sam-P/6) By Decreasing The Expression Of Peroxisome Proliferator-Activated Receptor Gamma 2 (PparĪ³2 ā€¦
  39. Breast-Feeding Modifies The Association Of PparĪ³2 Polymorphism Pro12Ala With Growth In Early Life: The Generation R Study
  40. Cannabinoid Receptor 1 Disturbance Of PparĪ³2 Augments Hyperglycemia Induction Of Mesangial Inflammation And Fibrosis In Renal Glomeruli
  41. Cascade Regulation Of PparĪ³2 And C/EbpĪ± Signaling Pathways By Celastrol Impairs Adipocyte Differentiation And Stimulates Lipolysis In 3T3-L1 Adipocytes
  42. Catalase And PparĪ³2 Genotype And Risk Of Rheumatoid Arthritis In Koreans
  43. Changes In Ucp2, PparĪ³2, And C/EbpĪ± Gene Expression Induced By A Neuropeptide Y (Npy) Related Receptor Antagonist In Overweight Rats
  44. Changes Of Adiposity In Response To Vitamin A Status Correlate With Changes Of PparĪ³2 Expression
  45. Chlorogenic Acid Functions As A Novel Agonist Of PparĪ³2 During The Differentiation Of Mouse 3T3-L1 Preadipocytes
  46. Cholesterol Suppresses Adipocytic Differentiation Of Mouse Adipose-Derived Stromal Cells Via PparĪ³2 Signaling
  47. Chromatin Accessibility And Transcription Factor Binding At The PparĪ³2 Promoter During Adipogenesis Is Protein Kinase Aā€Dependent
  48. Combined Effects Of The C161T And Pro12Ala PparĪ³2 Gene Variants With Insulin Resistance On Metabolic Syndrome: A Caseā€“Control Study Of A Central Tunisian ā€¦
  49. Common Polymorphisms In The PparĪ³2 And Irs-1 Genes And Their Interaction Influence Serum Adiponectin Concentration In Young Finnish Men
  50. Compressive Force Inhibits Adipogenesis Through Cox-2-Mediated Down-Regulation Of PparĪ³2 And C/EbpĪ±
  51. Correlation Between Polymorphism Of Pro12Ala Of PparĪ³2 And The First-Order Relatives Of Patients With Type 2 Diabetes Mellitus [J]
  52. Critical Roles Of The Histone Methyltransferase Mll4/Kmt2D In Murine Hepatic Steatosis Directed By Abl1 And PparĪ³2
  53. Cytosolic And Nuclear Distribution Of PparĪ³2 In Differentiating 3T3-L1 Preadipocytes
  54. D2 Thr92Ala And PparĪ³2 Pro12Ala Polymorphisms Interact In The Modulation Of Insulin Resistance In Type 2 Diabetic Patients
  55. Delta-Like Homolog1/Gata Binding Protein 2 Axis Mediates Leptin Inhibition Of PparĪ³2 Expression In Hepatic Stellate Cells In Vitro
  56. Deoxynivalenol Exposure Suppresses Adipogenesis By Inhibiting The Expression Of Peroxisome Proliferator-Activated Receptor Gamma 2 (PparĪ³2) In 3T3-L1 Cells
  57. Developmental And Nutritional Changes Of Ob And PparĪ³2 Gene Expression In Rat White Adipose Tissue
  58. Differential Effect Of PparĪ³2 Variants In The Development Of Type 2 Diabetes Between Native Japanese And Japanese Americans
  59. Differential Gene Regulation By PparĪ³ Agonist And Constitutively Active PparĪ³2
  60. Differential Modulation Of Cell Cycle, Apoptosis And PparĪ³2 Gene Expression By PparĪ³ Agonists Ciglitazone And 9-Hydroxyoctadecadienoic Acid In Monocytic Cells
  61. Differential PparĪ³2 And RxrĪ± Expression In The Differentiating 3T3-L1 Adipocyte
  62. Differential Transcriptional Expression Of PparĪ±, PparĪ³1, And PparĪ³2 In The Peritoneal Macrophages And T-Cell Subsets Of Non-Obese Diabetic Mice
  63. Differentiated Embryo Chondrocyte 1 (Dec1) Represses PparĪ³2 Gene Through Interacting With Ccaat/Enhancer Binding Protein Ī’ (C/EbpĪ²)
  64. Does PparĪ³2 Gene Pro12Ala Polymorphism Affect Nonalcoholic Fatty Liver Disease Risk? Evidence From A Meta-Analysis
  65. Does Pro 12 Ala Polymorphism Enhance The Physiological Role Of Pparš›¾2?
  66. Does Pro12Ala Polymorphism Enhance The Physiological Role Of PparĪ³2?
  67. Domain-Containing 7Ī‘ (Fbw7Ī‘) Causes Hepatosteatosis Through KrĆ¼ppel-Like Factor 5 (Klf5)/Peroxisome Proliferator-Activated Receptor Ī“2 (PparĪ³2) Pathway But Not ā€¦
  68. Downregulation Of Adipoq And PparĪ³2 Gene Expression In Subcutaneous Adipose Tissue Of Obese Adolescents With Hepatic Steatosis
  69. Down-Regulation Of PparĪ³2-Induced Adipogenesis By Pegylated Conjugated Linoleic Acid As The Pro-Drug: Attenuation Of Lipid Accumulation And Reduction Of ā€¦
  70. Ectopic Overexpression Of Swine PparĪ³2 Upregulated Adipocyte Genes Expression And Triacylglycerol In Skeletal Muscle Of Mice
  71. Effect Of Polymorphism Of PparĪ³2 Gene On Carcass Traits Of Swine.
  72. Effect Of PparĪ³2 Mrna Expression In 3T3-L1 Adipocytes With The Human Recombinant Adiponectin By Insulin
  73. Effect Of The Pro12Ala Polymorphism Of The PparĪ³2 Gene On Response To Pioglitazone Treatment In Menopausal Women
  74. Effect Of The Pro12Ala Polymorphism Of The PparĪ³2 Gene On Serum Adiponectin Changes
  75. Effect Of Tnf-Ī‘ On PparĪ³2 Mrna Expression In 3T3-L1 Adipocytes Transfected With The Human Recombinant Adiponectin
  76. Effect Of Zhengan Xifeng Decoction On Expressions Of PparĪ³2 Mrna And PparĪ³2 Protein Of Spontaneously Hypertensive Rats
  77. Effects Of PparĪ³2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of Dha
  78. Element-Binding Protein/Atf1 Inhibits Adipogenic Conversion Of 3T3-L1 Cells Ectopically Expressing Ccaat/Enhancer-Binding Protein (C/Ebp) Ī‘, C/Ebp Ī’, Or PparĪ³2
  79. Epigenetic Landscape In PparĪ³2 In The Enhancement Of Adipogenesis Of Mouse Osteoporotic Bone Marrow Stromal Cell
  80. Evidence For Genetic Epistasis In Human Insulin Resistance: The Combined Effect Of Pc-1 (K121Q) And PparĪ³2 (P12A) Polymorphisms
  81. Evidence For Greater Oxidative Substrate Flexibility In Male Carriers Of The Pro 12 Ala Polymorphism In PparĪ³2
  82. Expression Patterns Of PparĪ³2, Pgc-1Ī‘, And Mef2C And Their Association With Intramuscular Fat Content And Skeletal Muscle Tenderness Of Crossbred Simmental ā€¦
  83. Frequency Of Pro12Ala-Polymorphism Of The Gene PparĪ³2 In The Ukrainian Population And Its Possible Relation To The Development Of The Metabolic Syndrome
  84. Frequency Of The Pro12Ala Gene Poly Morphism PparĪ³2 In Ukrainian Population And Its Possible Role In Metabolic Syndrome Development
  85. Gcn2 In The Brain Programs PparĪ³2 And Triglyceride Storage In The Liver During Perinatal Development In Response To Maternal Dietary Fat
  86. Gene Expression Analysis Suggests That Ebf-1 And PparĪ³2 Induce Adipogenesis Of Nih-3T3 Cells With Similar Efficiency And Kinetics
  87. Genetic Epistasis Of Adiponectin And PparĪ³2 Genotypes In Modulation Of Insulin Sensitivity: A Family-Based Association Study
  88. Genetic Variants Of The PparĪ³2 Specific Region In Japanese Black Cattle.
  89. Ginsenoside Rb1 Promotes Adipogenesis In 3T3-L1 Cells By Enhancing PparĪ³2 And C/EbpĪ± Gene Expression
  90. Grasos Insaturados En El Peso Corporal Y En El Metabolismo De La Glucosa Y De Los LĆ­pidos En Mujeres Obesas Con El Genotipo Pro12Pro En El Gen PparĪ³2
  91. GsĪ± Signalling Suppresses PparĪ³2 Generation And Inhibits 3T3L1 Adipogenesis
  92. Gut-Derived Serotonin Contributes To The Progression Of Non-Alcoholic Steatohepatitis Via The Liver Htr2A/PparĪ³2 Pathway
  93. Heterogeneous Effects Of Gene Polymorphism On Type 2 Diabetes Risk: Lesson From The PparĪ³2 Pro12Ala
  94. Histone H3K9 Demethylase Jmjd2B Induces Hepatic Steatosis Through Upregulation Of PparĪ³2
  95. Homozygosity For The Ala Allele Of The PparĪ³2 Pro12Ala Polymorphism Is Associated With Reduced Risk Of Coronary Artery Disease
  96. Identification, Characterization, And Tissue Distribution Of Human Peroxisome Proliferator-Activated Receptor (Ppar) Isoforms PparĪ³2 Versus PparĪ³1 And Activation ā€¦
  97. Immunoreactivities Of PparĪ³2, Leptin And Leptin Receptor In Oviduct Of Chinese Brown Frog During Breeding Period And Pre-Hibernation
  98. Impact Of The Pro12Ala Polymorphism Of The PparĪ³2 Gene On Diabetes And Obesity In A Highly Consanguineous Population
  99. Implications Of Critical PparĪ³2, Adipoq And Fto Gene Polymorphisms In Type 2 Diabetes And Obesity-Mediated Susceptibility To Type 2 Diabetes In An Indian ā€¦
  100. Improved Prediction Of Early-Onset Coronary Artery Disease Using Apoe Ī•4, Bche-K, PparĪ³2 Pro12 And Enos T-786C In A Polygenic Model
  101. Improvement Of Cardiometabolic Markers After Fish Oil Intervention In Young Mexican Adults And The Role Of PparĪ± L162V And PparĪ³2 P12A
  102. In Patients With Comorbidity Of Essential Hypertension And Type 2 Diabetes Depending On Genetic Polymorphism PparĪ³2
  103. Influence Of Different Cla Isomers On Insulin Resistance And Adipocytokines In Pre-Diabetic, Middle-Aged Men With PparĪ³2 Pro12Ala Polymorphism
  104. Influence Of Different Cla Isomers On Insulin Resistance, Body Weight And Adipozytokines Is Dependent On PparĪ³2 Pro12Ala Polymorphism
  105. Influence Of Different Concentrations Of 15-Deoxy-ā–³~(12, 14)-Prostaglandin J_2 On PparĪ³2 Mrna Expression And Bone Metabolism Related Genes In Bone Marrow ā€¦
  106. Influence Of The Polymorphisms Tpr64Arg In The Ī’3-Adrenergic Receptor Gene And Pro12Ala In The PparĪ³2 Gene On Metabolic Syndrome-Related Phenotypes In An ā€¦
  107. Inhibition Of Adipocyte Differentiation By Mechanical Stretching Through Erk-Mediated Downregulation Of PparĪ³2
  108. Inhibition Of Adipogenesis By A Cooh-Terminally Truncated Mutant Of PparĪ³2 In 3T3-L1 Cells
  109. Inhibition Of Adipogenic Differentiation Of Bone Marrow Mesenchymal Stem Cells By All-Trans Retinoic Acid Through Direct Regulation Of PparĪ³2 By RarĪ³
  110. Inhibition Of Osf2/Cbfa1 Expression And Terminal Osteoblast Differentiation By PparĪ³2
  111. Inhibition Of PparĪ³2 Gene Expression By The Hif-1-Regulated Gene Dec1/Stra13: A Mechanism For Regulation Of Adipogenesis By Hypoxia
  112. Insulin And Oleic Acid Increase PparĪ³2 Expression In Cultured Mouse Hepatocytes
  113. Interaction Between PparĪ³2 Variants And Gender On The Modulation Of Body Weight
  114. Interaction Between Pro12Ala Polymorphism Of PparĪ³2 And Diet On Adiposity Phenotypes
  115. Interaction Effects Of The Leu162Val PparĪ± And Pro12Ala PparĪ³2 Gene Variants With Renal Function In Metabolic Syndrome Population
  116. Interaction Effects Of The Leu162Val Pparš›¼ And Pro12Ala Pparš›¾2 Gene Varaints With Renal Function In Metabolic Syndrome Population
  117. Interaction Of Dio2 T92A And PparĪ³2 P12A Polymorphisms In The Modulation Of Metabolic Syndrome
  118. Interaction Of PparĪ³2 Gene Pro12Ala And PparĪ± Gene Leu162Val Snps With Dietary Intake Of Fat In Determination Of Plasma Lipid Concentrations In Subjects At ā€¦
  119. Interactions Of The PparĪ³2 Polymorphism With Fat Intake Affecting Energy Metabolism And Nutritional Outcomes In Obese Women
  120. Inverse Effects Of The PparĪ³2 Pro12Ala Polymorphism On Measures Of Adiposity Over 15 Years In African Americans And Whites. The Cardia Study
  121. Irs1, Kcnj11, PparĪ³2 And Hnfā€1Ī‘: Do Amino Acid Polymorphisms In These Candidate Genes Support A Shared Aetiology Between Type 1 And Type 2 Diabetes?
  122. Is A Pro12Ala Polymorphism Of The PparĪ³2 Gene Related To Obesity And Type 2 Diabetes Mellitus In The Czech Population?
  123. Isomer-Specific Effects Of Cla On Gene Expression In Human Adipose Tissue Depending On PparĪ³2 P12A Polymorphism: A Double Blind, Randomized ā€¦
  124. Ketogenic Diet Regulates The Antioxidant Catalase Via The Transcription Factor PparĪ³2
  125. Leptin Gene (Tttc)N Microsatellite Polymorphism As Well As Leptin Receptor R223Q And PparĪ³2 P12A Substitutions Are Not Associated With Hypertensive ā€¦
  126. Lipin1 Is A Key Factor For The Maturation And Maintenance Of Adipocytes In The Regulatory Network With C/EbpĪ± And PparĪ³2
  127. Lipocalin Prostaglandin D Synthase And PparĪ³2 Coordinate To Regulate Carbohydrate And Lipid Metabolism In Vivo
  128. Long Non-Coding Rna Neat1 Associates With Srp40 To Temporally Regulate PparĪ³2 Splicing During Adipogenesis In 3T3-L1 Cells
  129. Lotus Leaf Aqueous Extract Improves Glucose Metabolism In Hfd-Induced Obese Rats By Regulating PparĪ³2 Expression
  130. Lotus Leaf Aqueous Extract Reduces Visceral Fat Mass And Ameliorates Insulin Resistance In Hfd-Induced Obese Rats By Regulating PparĪ³2 Expression
  131. Lovastatin Inhibits Adipogenic And Stimulates Osteogenic Differentiation By Suppressing PparĪ³2 And Increasing Cbfa1/Runx2 Expression In Bone Marrow ā€¦
  132. Mechanical Input Restrains PparĪ³2 Expression And Action To Preserve Mesenchymal Stem Cell Multipotentiality
  133. Molecular Scanning Of The Human Peroxisome Proliferator Activated Receptor Ī“ (HpparĪ³) Gene In Diabetic Caucasians: Identification Of A Pro12Ala PparĪ³2 Missense ā€¦
  134. Of PparĪ³2 And Leptin Genes In High Fat Diet Fed C57Bl/6J Mice And Retards In Vitro 3T3L1 Pre-Adipocyte Differentiation
  135. Of Vascular Remodeling And Metabolic Disorders In Patients With Essential Hypertension And Concomitant Type 2 Diabetes Depending On Genetic Polymorphism PparĪ³2
  136. P300 Interacts With The N-And C-Terminal Part Of PparĪ³2 In A Ligand-Independent And-Dependent Manner, Respectively
  137. Platycodin D Inhibits Lipogenesis Through AmpkĪ±-PparĪ³2 In 3T3-L1 Cells And Modulates Fat Accumulation In Obese Mice
  138. Polyhydroxylated Fullerene C60(Oh)44 Suppresses Intracellular Lipid Accumulation Together With Repression Of Intracellular Superoxide Anion Radicals And Subsequent PparĪ³2 Expression During Spontaneous Differentiation Of Op9 Preadipocytes Into Adipocytes
  139. Polymorphism Of Cyp46A1 And PparĪ³2 Genes In Risk Prediction Of Primary Open Angle Glaucoma Among North Indian Population
  140. Ppar (Peroxisome-Proliferator-Activated Receptor) Ī“2 Gene Expression In Brown Adipocytes: Intracellular Signalling And Effects On PparĪ³2 And PparĪ³1 Protein Levels
  141. PparĪ³ Knockdown By Engineered Transcription Factors: Exogenous PparĪ³2 But Not PparĪ³1 Reactivates Adipogenesis
  142. PparĪ³2 C1431T Genotype Increases Metabolic Syndrome Risk In Young Men With Low Cardiorespiratory Fitness
  143. PparĪ³2 C1431T Polymorphism Interacts With The Antiobesogenic Effects Of Kochujang, A Korean Fermented, Soybean-Based Red Pepper Paste, In Overweight ā€¦
  144. PparĪ³2 Expression In Growth Plate Chondrocytes Is Regulated By P38 And Gskā€3
  145. PparĪ³2 Expression In Osteonecrosis Of The Femoral Head
  146. PparĪ³2 Gene Expression Of Swine Adipose Tissue, Liver, Heart And Kidney In Cold Stress.
  147. PparĪ³2 Gene Pro12Ala And PparĪ± Gene Leu162Val Single Nucleotide Polymorphisms Interact With Dietary Intake Of Fat In Determination Of Plasma Lipid ā€¦
  148. PparĪ³2 Gene Pro12Ala And PparĪ± Gene Leu162Val Snps Interact With Dietary Intake Of Fat In Determination Of Plasma Lipid Concentrations
  149. PparĪ³2 Is A Key Driver Of Longevity In The Mouse
  150. PparĪ³2 Nuclear Receptor Controls Multiple Regulatory Pathways Of Osteoblast Differentiation From Marrow Mesenchymal Stem Cells
  151. PparĪ³2 P12A Polymorphism And Albuminuria In Patients With Type 2 Diabetes: A Meta-Analysis Of Caseā€“Control Studies
  152. PparĪ³2 Piles On The Pounds
  153. PparĪ³2 Pro12A1A And TnfĪ±-308 G/A Interaction On Features Of Metabolic Syndrome.
  154. PparĪ³2 Pro12Ala Polymorphism And Insulin Resistance In Japanese Hypertensive Patients
  155. PparĪ³2 Pro12Ala Polymorphism In Relation To Free Fatty Acids Concentration And Composition In Lean Healthy Czech Individuals With And Without Family ā€¦
  156. PparĪ³2 Pro12Ala Polymorphism Is Associated With Improved Lipoprotein Lipase Functioning In Adipose Tissue Of Insulin Resistant Obese Women
  157. PparĪ³2 Pro12Ala Polymorphism Is Associated With Sustained Virological Response In Hiv/Hcv-Coinfected Patients Under Hcv Therapy
  158. PparĪ³2 Pro12Ala Polymorphism Was Associated With Favorable Cardiometabolic Risk Profile In Hiv/Hcv Coinfected Patients: A Cross-Sectional Study
  159. PparĪ³2 Protects Against Obesity By Means Of A Mechanism That Mediates Insulin Resistance
  160. PparĪ³2 Regulates A Molecular Signature Of Marrow Mesenchymal Stem Cells
  161. PparĪ³2 Regulates Lipogenesis And Lipid Accumulation In Steatotic Hepatocytes
  162. PparĪ³2-Mediated Proteolytic Degradation Of B-Catenin Determines An Anti-Osteoblastic Effect Of Anti-Diabetic Tzds
  163. Pro12Ala Mutation In The Peroxisome Proliferator-Activated Receptor Ī“2 (PparĪ³2) And Severe Obesity: A Caseā€“Control Study
  164. Pro12Ala Polymorphism In PparĪ³2 Associated With Depression In Chinese Nonagenarians/Centenarians
  165. Pro12Ala Polymorphism In The Peroxisome Proliferator-Activated Receptor-Ī“2 (PparĪ³2) Is Associated With Higher Levels Of Total Cholesterol And Ldl-Cholesterol In Male ā€¦
  166. Pro12Ala Polymorphism Of The PparĪ³2 Gene And Fat Distribution In Korean Obese Patients
  167. Pro12Ala Polymorphism Of The PparĪ³2 Gene Interacts With A Mediterranean Diet To Prevent Telomere Shortening In The Predimed-Navarra Randomized Trial
  168. Pro12Ala Polymorphism Of The PparĪ³2 Locus Modulates The Relationship Between Energy Intake And Body Weight In Type 2 Diabetic Patients
  169. Pro12Ala Polymorphism On The PparĪ³2 Gene And Weight Loss After Aerobic Training: A Randomized Controlled Trial
  170. Promoter Of PparĪ³2 Cloning And Correlation Analysis Of Methylation And Gene Expression
  171. Promoterā€“Enhancer Looping At The PparĪ³2 Locus During Adipogenic Differentiation Requires The Prmt5 Methyltransferase
  172. Protein Arginine Methyltransferase 5 (Prmt5) Promotes Gene Expression Of Peroxisome Proliferator-Activated Receptor Ī“2 (PparĪ³2) And Its Target Genes During ā€¦
  173. Quantitative Evaluation Of Common Polymorphism (Rs1801282) In The PparĪ³2 Gene And Hypertension Susceptibility
  174. RarĪ³-C-Fos-PparĪ³2 Signaling Rather Than Ros Generation Is Critical For All-Trans Retinoic Acid-Inhibited Adipocyte Differentiation
  175. Reduced Irs-2 And Glut4 Expression In PparĪ³2-Induced Adipocytes Derived From C/EbpĪ² And C/EbpĪ“-Deficient Mouse Embryonic Fibroblasts
  176. Reduced PparĪ³2 Expression In Adipose Tissue Of Male Rat Offspring From Obese Dams Is Associated With Epigenetic Modifications
  177. Regulation Of Hepatic PparĪ³2 And Lipogenic Gene Expression By Melanocortin
  178. Relationship Between PparĪ³2 Pro12Ala Polymorphism And Type 2 Diabetes Mellitus In Chinese Han Population: A Meta-Analysis
  179. Relationship Of Pro12Ala Polymorphism Of Peroxisome Proliferator Activated Receptor Ī“2 (PparĪ³2) Gene On The Therapeutic Efficacy Of Rosiglitazone In The Treatment Of ā€¦
  180. Relationships Of PparĪ³ And PparĪ³2 Mrna Levels To Obesity, Diabetes And Hyperinsulinaemia In Rhesus Monkeys
  181. Research Progress In Interrelationship Of PparĪ³2 And Pgc-1 Genes Mononucleotide Polymorphism With Type 2 Diabetes [J]
  182. Research Progress On Cardio-Cerebrovascular Disease Visfatin, A-Fabp, PparĪ³2 Gene Polymorphism And Their Relationships With Cardio/Cerebrovascular Disease.
  183. Resistance With Ucp2-866G/A, Ucp2 45Bp Ins/Del, Ucp3-55C/T, Ghsr1A Rs2922126, Ghsr1A Rs509035 And Pro12Ala PparĪ³2 Gene Polymorphisms In ā€¦
  184. Role Of Ox-Papcs In The Differentiation Of Mesenchymal Stem Cells (Mscs) And Runx2 And PparĪ³2 Expression In Mscs-Like Of Osteoporotic Patients
  185. Rosiglitazone Prevents The Impairment Of Human Islet Function Induced By Fatty Acids: Evidence For A Role Of PparĪ³2 In The Modulation Of Insulin Secretion
  186. Safflower Yellow Improves Insulin Sensitivity In High Fat Dietā€Induced Obese Mice By Promoting PparĪ³2 Expression In Subcutaneous Adipose Tissue
  187. Sakuranetin Induces Adipogenesis Of 3T3-L1 Cells Through Enhanced Expression Of PparĪ³2
  188. Selective Disruption Of PparĪ³2 Impairs The Development Of Adipose Tissue And Insulin Sensitivity
  189. Sida Rhomboidea. Roxb Leaf Extract Down-Regulates Expression Of PparĪ³2 And Leptin Genes In High Fat Diet Fed C57Bl/6J Mice And Retards In Vitro 3T3L1 Pre ā€¦
  190. Stimulation Of Adipogenesis In Fibroblasts By PparĪ³2, A Lipid-Activated Transcription Factor
  191. Studies On Screening Of Por12Ala Snp In PparĪ³2 Gene Among Gujarat Subjects.
  192. Study Of A New PparĪ³2 Promoter Polymorphism And Haplotype Analysis In A French Population
  193. Study On Distribution Of Pro12Ala Single Nucleotide Polymorphism Of PparĪ³2 Gene In Randomly Sampled Diabetic Population From Guwahati City
  194. Supplementation With Ī©3 Polyunsaturated Fatty Acids Decreases Fasting Insulin And Hemoglobin A1C Levels In Healthy Mexican Adults: The Role Of PparĪ³2 P12A
  195. Suppression Of Osteoblast Phenotype In The Marrow Mesenchymal Stem Cell By Nuclear Receptor PparĪ³2
  196. Tandem Repeat Of C/Ebp Binding Sites Mediates PparĪ³2 Gene Transcription In Glucocorticoidā€Induced Adipocyte Differentiation
  197. Tanshinol Alleviates Impaired Bone Formation By Inhibiting Adipogenesis Via Klf15/PparĪ³2 Signaling In Gio Rats
  198. Tea Catechin Suppresses Adipocyte Differentiation Accompanied By Down-Regulation Of PparĪ³2 And C/EbpĪ± In 3T3-L1 Cells
  199. Tfe3 And Tfeb Transcriptionally Regulate PparĪ³2 Expression In Adipocytes And Mediate Adiponectin And Glucose Levels In Mice
  200. The Association Between The PparĪ³2 Pro12Ala Polymorphism And Nephropathy Susceptibility In Type 2 Diabetes: A Meta-Analysis Based On 9,176 Subjects
  201. The Association Between The Pro12Ala Variant In The PparĪ³2 Gene And Type 2 Diabetes Mellitus And Obesity In A Chinese Population
  202. The Association Of Pro12Ala Polymorphism In PparĪ³2 With Lower Carotid Artery Imt In Japanese
  203. The Common PparĪ³2 Pro12Ala Polymorphism Is Associated With An Increased Risk Of Coronary Artery Disease (Cad) In Iranian Patients With Type 2 Diabetes ā€¦
  204. The Effect Of The Ala12 Allele Of The Peroxisome Proliferator-Activated Receptor-2 (PparĪ³2) Gene On Bmi In Iranian Diabetic And ā€¦
  205. The Formation Of Brown Adipose Tissue Induced By Transgenic Over-Expression Of PparĪ³2
  206. The Frequency Of Alleles Of The Pro12Ala Polymorphism In PparĪ³2 Is Different Between Healthy Controls And Patients With Type 2 Diabetes
  207. The Human Peroxisome Proliferator-Activated Receptor Ī“2 (PparĪ³2) Pro12Ala Polymorphism Is Associated With Decreased Risk Of Diabetic Nephropathy In Patients With ā€¦
  208. The Identification And Characterization Of A Stat 1 Binding Site In The PparĪ³2 Promoter
  209. The In Vivo Effects Of The Pro12Ala PparĪ³2 Polymorphism On Adipose Tissue Nefa Metabolism: The First Use Of The Oxford Biobank
  210. The Influence Of The Pro12Ala Mutation Of PparĪ³2 Receptor Gene Clinical Character In Metabolic Syndrome
  211. The Influence Of The Pro12Ala Mutation Of PparĪ³2 Receptor Gene On Ī’-Cells Restoration And Insulin Resistance In Type 2 Diabetes With Hypertension
  212. The Minor Allele Of The PparĪ³2 Pro12Ala Polymorphism Is Associated With Lower Postprandial Tag And Insulin Levels In Non-Obese Healthy Men
  213. The Modulation Of PparĪ³1 And PparĪ³2 Mrna Expression By Ciglitazone In Cd3/Cd28-Activated NaĆÆve And Memory Cd4+ T Cells
  214. The PparĪ³2 A/B-Domain Plays A Gene-Specific Role In Transactivation And Cofactor Recruitment
  215. The PparĪ³2 Amino Acid Polymorphism Pro 12 Ala Is Prevalent In Offspring Of Type Ii Diabetic Patients And Is Associated To Increased Insulin Sensitivity In A Subgroup Of ā€¦
  216. The PparĪ³2 P12A Polymorphism Is Not Associated With All-Cause Mortality In Patients With Type 2 Diabetes Mellitus
  217. The PparĪ³2 Polymorphism Pro12Ala Is Associated With Better Insulin Sensitivity In The Offspring Of Type 2 Diabetic Patients
  218. The PparĪ³2 Pro12Ala Variant Is Protective Against Progression Of Nephropathy In People With Type 2 Diabetes
  219. The PparĪ³2 Pro12Ala Variant Predicts Esrd And Mortality In Patients With Type 1 Diabetes And Diabetic Nephropathy
  220. The Pro12Ala Polymorphism In PparĪ³2 Gene Affects Lipid Parameters In Greek Primary School Children: A Case Of Gene-To-Gender Interaction
  221. The Pro12Ala Polymorphism In The Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PparĪ³2) Is Associated With Increased Risk Of Coronary Artery ā€¦
  222. The Pro12Ala Polymorphism In The PparĪ³2 Gene Is Not Associated With An Increased Risk Of Nafld In Iranian Patients With Type 2 Diabetes Mellitus
  223. The Pro12Ala Polymorphism Of PparĪ³2 Gene And Susceptibility To Type 2 Diabetes Mellitus In A Polish Population
  224. The Pro12Ala Polymorphism Of PparĪ³2 Modulates Beta Cell Function And Failure To Oral Glucoseā€Lowering Drugs In Patients With Type 2 Diabetes
  225. The Pro12Ala Polymorphism Of The PparĪ³2 Gene Interacts With A Mediterranean Diet To Prevent Telomere Shortening In The Predimed-Navarra Randomized Trial
  226. The Pro12Ala Polymorphism Of The PparĪ³2 Gene Is Associated With Hepatic Glucose Uptake During Hyperinsulinemia In Subjects With Type 2 Diabetes Mellitus
  227. The Pro12Ala Polymorphism Of The PparĪ³2 Gene Regulates Weight From Birth To Adulthood
  228. The Pro12Ala PparĪ³2 Gene Missense Mutation Is Associated With Obesity And Insulin Resistance In Swedish Middleā€Aged Men
  229. The Pro12Ala PparĪ³2 Variant Determines Metabolism At The Gene-Environment Interface
  230. The Proline 12 Alanine Substitution In The PparĪ³2 Gene Is Associated With Increased Extent Of Coronary Artery Disease In Men
  231. The Rate Of Decline Of Glomerular Filtration Rate May Not Be Associated With Polymorphism Of The PparĪ³2 Gene In Patients With Type 1 Diabetes And Nephropathy
  232. The Rate Of Decline Of Glomerular Filtration Rate May Not Be Associated With Polymorphism Of The Pparš›¾2 Gene In Patients With Type 1 Diabetes And ā€¦
  233. The Relationship Among Peroxisome Proliferator-Activated Receptor Ī“2 (PparĪ³2) Gene Mutation And Leptin Secretion And Adiposity In Shijiazhuang Area
  234. The relationship between the Pro12ala polymorphism of the PparĪ³2 gene and the metabolic syndrome in a population of Central Romania diagnosed ā€¦
  235. Tob2 Inhibits PparĪ³2 Expression By Sequestering Smads And C/EbpĪ± During Adipocyte Differentiation
  236. Tonebp Suppresses Adipogenesis And Insulin Sensitivity By Blocking Epigenetic Transition Of PparĪ³2
  237. Transcription Coactivator Trap220 Is Required For PparĪ³2-Stimulated Adipogenesis
  238. Transcriptional Activation Of Cidec By PparĪ³2 In Adipocyte
  239. Transformation And Amplification Of Mouse PparĪ³2 Gene Expression Vector Pcdna3-PparĪ³2
  240. Transient Expression, Purification And Characterisation Of Human Full-Length PparĪ³2 In Hek293 Cells
  241. Transient Overexpression Of PparĪ³2 And C/EbpĪ± In Mesenchymal Stem Cells Induces Brown Adipose Tissue Formation
  242. Type2 Diabetes Susceptible Loci PparĪ³2 Is Not Associated With Type1 Diabetes At Age Of~ 30 In Bangladeshi Healthy People
  243. Ucps And PparĪ³2 Mrna In Diet Induced Obesity Resistant Rats
  244. Upregulation Of Gene Encoding Adipogenic Transcriptional Factors C/EbpĪ± And PparĪ³2 In Denervated Muscle
  245. Uteroplacental Insufficiency Increases Visceral Adiposity And Visceral Adipose PparĪ³2 Expression In Male Rat Offspring Prior To The Onset Of Obesity
  246. Weight Loss Reduces Expression Of Srebp1C/Add1 And PparĪ³2 In Adipose Tissue Of Obese Women
  247. Wnt3A Disrupts Gr-Tead4-PparĪ³2 Positive Circuits And Cytoskeletal Rearrangement In A Ī’-Catenin-Dependent Manner During Early Adipogenesis
  248. Ī’-Catenin Directly Sequesters Adipocytic And Insulin Sensitizing Activities But Not Osteoblastic Activity Of PparĪ³2 In Marrow Mesenchymal Stem Cells

Related Posts

Shopping Cart
Scroll to Top